WEBINAR
Considerations for Microbial Fermentation: Single Use vs. Stainless Steel Fermenters
For decades, microbial fermentation has been used for the commercialization of biologics, with the fermentation of recombinant proteins such as insulin in stainless steel bioreactors as large as 100,000 L. A long-standing favorite within the industry, these stainless-steel fermenters boast a long history in biopharma manufacturing — though are not without their limitations.
Recent innovations in single-use fermenters, which offer an agile and cost-effective solution with reduced cleaning and validation requirements, have led single-use fermenters to gain ground quickly — but knowing when to use stainless steel versus single-use fermenters, or even a hybrid approach, can be challenging.
Access the On-Demand Webinar to:
- Learn about the pros, cons and use cases for each type of technology
- Discover what the speakers think the future holds when it comes to their sustainability in the industry.
- Learn what to look for in a CDMO when deciding to partner with for fermentation needs.
Presented by:
Gregor Awang, Director, Biologics Process Development, BIOVECTRA
Cameron Graham, Pharmaceutical Process Engineer, BIOVECTRA
Brady Cole, Vice President Equipment Solutions, ABEC
With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.
© Copyright BIOVECTRA 2022.
All Rights Reserved.